Status
Conditions
Study type
Funder types
Identifiers
About
The purpose of this study is to estimate the prevalence of Treatment Resistant Depression (TRD) among Major Depressive Disorder (MDD) participants being treated in a psychiatry reference site (example, clinic, ambulatory, hospital, day-hospital) in 4 Latin American countries: Argentina, Brazil, Colombia and Mexico; and to evaluate all and depression-related healthcare resource utilization in TRD participants.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Phase 1:
Phase 2:
Diagnosis of Treatment Resistant Depression (TRD), to be described by the investigator, based on the criteria:
Adequate follow-up and treatment with at least 2 antidepressants
Without complete response to treatment (based on Montgomery-Asberg Depression Rating Scale [MADRS])
Exclusion Criteria:
Participants diagnosed of psychosis, schizophrenia, bipolar disorder, schizoaffective disorder, or dementia
Participants with substance dependence considered serious by the investigator
Participant currently participating in another clinical study
1,539 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal